Nutex Health Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $0 $23k
$60k +159.97%
$1.4m +2168.89%
$1.6m +16.07%
$18.8m +1085.02%
$219.3m +1066.84%
$247.6m +12.93%
$479.9m +93.80%
$875.3m +82.36%
$846.7m -3.26%
Cost of Goods and Services Sold $0 $30k $31k $830k $910k $14.6m
$205.8m +1305.35%
$212.9m +3.42%
$283.7m +33.27%
$431.0m +51.92%
$412.7m -4.24%
Gross Profit $0 ($7k)
$29k +497.47%
$536k +1743.43%
$676k +26.16%
$4.1m +513.27%
$13.5m +224.41%
$34.8m +158.50%
$196.3m +464.39%
$444.3m +126.37%
$434.0m -2.31%
Research and Development Expense $768k $557k $286k
Marketing and Advertising Expense $6.5m
Selling and Marketing Expense $578k $167k $69.8m
General and Administrative Expense $449k $1.8m $1.2m $3.7m $3.3m $12.2m $18.0m $33.2m $41.9m $51.7m $69.8m
Labor and Related Expense $108.4m $117.5m $158.1m
Amortization of Intangible Assets $534k $118k $59k $1.2m $1.6m $1.5m $1.3m
Operating Expenses $5.7m $1.9m $7.4m $5.9m $13.2m $420.1m $66.5m $65.6m $168.7m $69.8m
Operating Income (Loss) ($449k)
($5.7m) -1169.06%
($1.8m) +67.84%
($6.9m) -276.82%
($5.2m) +24.79%
($9.0m) -73.84%
($406.6m) -4408.71%
($31.8m) +92.19%
$130.7m +511.34%
$275.6m +110.89%
$364.3m +32.16%
Interest Expense ($3k) $367k $642k $92k $335k $12.5m $16.3m $19.8m
Interest Expense, Debt $339k $631k $631k $335k $19.8m
Interest Income, Other $0
Investment Income, Interest $4k $1k $917
Other Nonoperating Income (Expense) ($315k) ($984k) ($219k) ($502k) ($5.6m) ($559k) ($399k) $669k ($8.6m)
Interest Expense (non-operating) $19.9m $22.2m $19.8m
Nonoperating Income (Expense) ($2k)
Other Expenses $30.4m $30.4m $31.1m $44.8m
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $7.1m ($5.7m) ($14.7m) ($419.6m) ($48.5m) $109.8m $244.8m $343.5m
Current Income Tax Expense (Benefit) $0 $0 $13.1m $5.1m $14.5m $64.4m $71.0m
Income Tax Expense (Benefit) $0 $0 ($985k) $13.1m ($5.1m) $15.0m $64.4m $71.0m
Net Income (Loss) Attributable to Parent ($7.4m)
$582k +107.83%
($2.8m) -583.50%
($7.1m) -152.87%
($5.7m) +20.60%
($13.7m) -141.92%
($424.8m) -3007.70%
($45.8m) +89.22%
$52.1m +213.78%
$70.8m +35.88%
$179.9m +154.16%
Net Income (Loss) Available to Common Stockholders, Basic ($7.4m)
$582k +107.83%
($950k) -263.24%
($7.1m) -649.01%
$0 +100.00%
$13.7m +7593679900.00%
($1) -100.00%
($0) +89.55%
$52.1m +74422914385.71%
$70.8m +35.88%
$179.9m +154.16%
Net Income (Loss) Attributable to Noncontrolling Interest $0 $891 ($8.0m) $2.4m $42.7m $109.6m $179.9m
Earnings Per Share, Basic ($0.19) $0.01 ($0.56) ($1.96) $0.18 $0.22 ($0.67) ($0.07) $10.23 $11.13 $26.79
Earnings Per Share, Diluted ($0.19) $0.18 $0.22 ($0.67) ($0.07) $9.69 $10.48 $25.80
Income (Loss) from Continuing Operations, Per Basic Share ($0) ($0) ($0) ($2) $0 $0 ($1) ($0) $10 $11
Weighted Average Number of Shares Outstanding, Basic 634.9m 661.2m 5.1m 6.4m 6.9m
Weighted Average Number of Shares Outstanding, Diluted 39.7m 5.5m 6.8m 7.1m
Additional Financial Items
Business Combination, Acquisition Related Costs $3.9m $43k $0 $0
Costs and Expenses $0 $30k $31k $830k $910k $14.6m $205.8m $212.9m $283.7m $431.0m
Goodwill, Impairment Loss $3.5m $0 $398.1m $3.2m $0 $0
Other Cost and Expense, Operating $49.0m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($451k) ($6.0m) ($2.8m) $7.1m $5.7m $13.7m $424.8m $45.8m $52.2m $70.8m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($5.5m) $13.7m $8.0m $2.4m $43.1m
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($7.0m) $6.6m $0 $119k $0 $8.0m $2.4m $43.1m $109.6m